BioPorto Receives Intention To Grant For NGAL Exclusion Patent In Europe

Published: Feb 21, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The European Patent Office has published intention to grant BioPorto’s patent no. EP2064553 regarding exclusion of acute kidney injury. The patent is part of BioPorto’s IP rights in the NGAL area and is complementary to the NGAL cutoff patent.

Help employers find you! Check out all the jobs and post your resume.

Back to news